The face of the ID profession is changing, and we need to change with it. You’re invited to learn more by participating in a webinar, Reflecting the Faces of ID: Governance Changes for the Future, on Nov. 28 at 12 p.m. EST.

The Centers for Medicare & Medicaid Services issued a final rule on Nov. 2 on proposed changes that would dramatically alter the Outpatient Evaluation & Management (E/M) codes.

Before patients receive IV antimicrobial infusion therapy outside of the hospital – whether at home, a doctor’s office or a skilled nursing facility – an ID specialist should review the order to ensure the most appropriate treatment, suggest updated IDSA guidelines.

Data recently released by the Centers for Disease Control and Prevention shows the number of cases of acute hepatitis C more than tripled between 2010 and 2016, with 41,000 new infections in 2016 alone.

IDSA continues to be deeply concerned about the ongoing exodus of companies from antibiotic research and development and continued news that small antibiotic companies are facing significant financial struggles. 

The Trump administration is proposing a significant expansion of the criteria used to determine if individuals applying for green cards may be considered a “public charge,” and potentially denied entry to the United States or permanent legal status here.

The Centers for Medicare and Medicaid Services (CMS) has issued the 2019 Physician Fee Schedule Final Rule, which contains final determinations for next year’s clinical laboratory fee schedule (CLFS).

In a new op-ed in The Hill, IDSA President Cynthia Sears, MD, FIDSA writes about the rise of antibiotic resistantinfections and shares results of a new survey that show only about half of Americans know enough about the correct use of antibiotics to prevent resistance from occurring. Read this and other media articles featuring IDSA spokespersons over the past two weeks.